Q1 2022 Praxis Precision Medicines Inc Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Praxis Precision Medicines First Quarter 2022 Corporate Update, Question and Answer Conference Call. (Operator Instructions)
And now, it is my pleasure to hand the conference over to your first speaker today, Alex Kane, Vice President, Investor Relations and Corporate Communications at Praxis. Thank you. Please go ahead.
Thank you, Paul. Good afternoon, everyone, and thank you for joining us today for our first quarter 2022 corporate update Q&A call. With me on the call is our President and Chief Executive Officer, Marcio Souza; our Chief Medical Officer, Bernard Ravina; and our CFO, Tim Kelly. Following the press releases and video update issued this afternoon, we will focus today's call on your questions.
We ask that you keep to one question initially, and then please feel free to rejoin the queue for follow-up questions as needed.
Before we proceed, I would like to remind you that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |